Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABUNDIA GLOBAL IMPACT GROUP, INC.HUSA · Entity 7206 | Director | September 06, 2017 | September 08, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABUNDIA GLOBAL IMPACT GROUP, INC.
Report date September 06, 2017 · Filed September 08, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.49 · Expires 2027-09-06 | Direct | 50,000 |
Reported balance
After 2017-09-06 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2017-09-06 · Grant · Acquired 50,000 · Balance 50,000 F2: The options were granted on September 6, 2017 and are exercisable six months from the date of grant, subject to vesting. The options vest 20% on the date of grant and 80% nine months from the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.20 · Expires 2018-06-02 | Direct | 3,333 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 3,333 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.05 · Expires 2019-06-09 | Direct | 3,333 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 3,333 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.08 · Expires 2020-06-15 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 25,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.07 · Expires 2021-06-13 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 25,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.65 · Expires 2022-06-11 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 100,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.31 · Expires 2023-06-11 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 25,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2024-06-10 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 50,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.20 · Expires 2025-06-09 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 50,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.20 · Expires 2026-03-15 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 10,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.22 · Expires 2026-06-07 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 50,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.22 · Expires 2026-06-07 | Direct | 150,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 150,000 |
| Common StockSEC Table I · non-derivative | Direct | 2,832,831 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,832,831 |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 119,034 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 119,034 |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.50 · Expires 2018-06-23 | Direct | 100,000 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 100,000 |
| 12% Series A Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.20 · Expires 2050-12-31 | Direct | 20 |
Reported balance
Holding disclosure · report date 2017-09-06 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 20 F1: Convertible preferred stock has no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Convertible preferred stock has no expiration date.
F2: The options were granted on September 6, 2017 and are exercisable six months from the date of grant, subject to vesting. The options vest 20% on the date of grant and 80% nine months from the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2017 Filed Sep 8, 2017 17:21 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001270061-17-000005 · primary_doc.xml · derivative · entry 16 TAWES ORRIE LEE · CIK 0001071405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-06 F2 · derivative.exercise_date: The options were granted on September 6, 2017 and are exercisable six months from the date of grant, subject to vesting. The options vest 20% on the date of grant and 80% nine months from the grant date. Read SEC document |
| January 31, 2017 Filed Feb 1, 2017 18:27 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | Purchase12% Series A Convertible Preferred Stock · Derivative | 20 | $1,000.00 Strike: $0.20 | $20,000.00 |
DisclosureSEC source: 0001071405-17-000001 · primary_doc.xml · derivative · entry 15 TAWES ORRIE LEE · CIK 0001071405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20 Underlying: Common Stock · 100,000 shares Expires 2050-12-31 F1 · derivative.expiration_date: Convertible preferred stock has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.